Presented by:
ACPE # Pending
First-Time Offering; Initial Release Date Thursday, September 22, 2022
Successful completion of this activity counts as Live ACPE CE.
Masks are encouraged, but not mandatory.
Benjamin Pontefract, PharmD, BCPS
Ferris State University College of Pharmacy
5:30 - 6:30 PM - Board Meeting
6:30 - 7:30 PM - CE Presentation
RSVP Deadline:
September 20th
We recommend that you create a WMed account before attending one of our meetings. Please see our Help Page for detailed instructions on creating a WMed account and claiming your CE credits.
Describe the clinical utility of nirmatrelvir/ritonavir
Describe the current data supporting the use of the most recent COVID-19 monoclonal antibody
Compare molnupiravir and outpatient remdesivir
In support of improving patient care, this activity has been planned and implemented by Western Michigan University Homer Stryker M.D. School of Medicine and Western Michigan Society of Health-System Pharmacists. Western Michigan University Homer Stryker M.D. School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit amount subject to change.
Pharmacists & Pharmacy Technicians
Western Michigan University Homer Stryker M.D. School of Medicine designates this activity for 1.0 contact hours for pharmacists and pharmacy technicians. Pharmacists and pharmacy technicians should claim only credit commensurate with the extent of their participation in the activity.
For technical assistance, email webmaster@wmshp.net.
Click here to view our Privacy Policy.